ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 152 filers reported holding ARRAY BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,260,000 | +11.1% | 82,909 | +22.7% | 0.02% | 0.0% |
| Q2 2018 | $1,134,000 | -20.8% | 67,560 | -23.0% | 0.02% | -25.0% |
| Q1 2018 | $1,432,000 | +124.5% | 87,760 | +76.0% | 0.02% | +118.2% |
| Q4 2017 | $638,000 | +131.2% | 49,860 | +122.0% | 0.01% | +120.0% |
| Q3 2017 | $276,000 | +36.0% | 22,460 | -18.3% | 0.01% | +66.7% |
| Q1 2015 | $203,000 | -41.2% | 27,500 | -63.7% | 0.00% | -50.0% |
| Q2 2014 | $345,000 | -48.0% | 75,700 | -48.2% | 0.01% | -50.0% |
| Q2 2013 | $664,000 | – | 146,199 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |